American Lung Association Announces New Investments in Lung Disease Research
Research Awards Nationwide 2016-2017 includes research conducted in Texas
(October 19, 2016) -
For more information please contact:
The American Lung Association recently unveiled its Research Awards Nationwide 2016-2017 report that highlights the novel and innovative research projects supported by the organization, including projects conducted in Texas. The goal of these research awards is to discover effective prevention and treatment strategies as well as cures for lung diseases, such as asthma, lung cancer, pulmonary fibrosis, chronic obstructive pulmonary disease (COPD) and more.
Through its Airways Clinical Research Centers (ACRC) and Awards and Grants Program, the American Lung Association funds high quality research and will be funding more than $6.5 million in 2016-2017. The program supports laboratory and patient-centered research and is an essential cornerstone of the Lung Association’s mission to save lives by improving lung health and preventing lung disease.
“In Texas we see first-hand the toll lung diseases, such as asthma, lung cancer and COPD, can have on families and loved ones,” said Holly Torres, Executive Director for the American Lung Association in Texas. “Scientific research is key to reducing the burden of these lung diseases and saving more lives. The American Lung Association is extremely proud to fund six promising research efforts in Texas that will offer needed support to those in our community suffering from lung disease.”
Over the next 12 months, the American Lung Association is supporting the following local lung disease research projects through its Awards and Grants Program in Texas.
• Harry Karmouty-Quintana, PhD, University of Texas Health Science Center at Houston
o Alternative Polyadenylation in the Pathogenesis of COPD
• Krithika Lingappan, MD, Baylor College of Medicine
o Role of Growth Differentiation Factor (GDF15) in Alveolarization and Pulmonary Angiogenesis
• Binoy Shivanna, MD, DM, Baylor of College of Medicine
o Adrenomedullin as a Novel Target for Regulating Acute Hyperoxic Lung Injury
• Bartosz Szczesny, PhD, University of Texas Medical Branch at Galveston
o Role of Mitochondrial DNA Damage in Pulmonary Inflammation
• Amit Parulekar, MD, Baylor College of Medicine
o The Impact of Fungal Sensitization and Airway Fungal Microbiome on Asthma Severity
• Jung-whan Kim, PhD, University of Texas at Dallas
o GLUT1, a Novel Diagnostic and Therapeutic Target for Squamous Carcinoma
Medical advances made possible by the research contributions of the Lung Association have advanced treatment options, improved quality of life and patient care for a variety of lung diseases. For example, in Dr. Karmouty-Quintana’s research they hope to determine how the shortening of three prime untranslated regions may contribute to the development of COPD.
“We hope that our research will deepen our understanding of how COPD develops and help us find new treatments for this crippling disease that affects millions of Americans,” he said.
In addition to the Awards and Grants program, the ACRC network is the nation's largest not-for-profit network of clinical research centers dedicated to asthma and COPD treatment research. The network consists of a data coordinating center managed by a team at Johns Hopkins University, along with 17 clinical research centers nationwide, including the Baylor College of Medicine Airways Clinical Research Center in Houston.
The Research Awards Nationwide 2016-2017 report is interactive and available online at Lung.org/ran. For media interested in learning more about new and promising lung disease research funded by the Lung Association or speaking with an expert about lung disease, contact Heather Mangan at [email protected] or 312-801-7631.
About the American Lung Association in Texas
The American Lung Association is the leading organization working to save lives by improving lung health and preventing lung disease, through research, education and advocacy. The work of the American Lung Association is focused on four strategic imperatives: to defeat lung cancer; to improve the air we breathe; to reduce the burden of lung disease on individuals and their families; and to eliminate tobacco use and tobacco-related diseases. For more information about the American Lung Association, a holder of the Better Business Bureau Wise Giving Guide Seal, or to support the work it does, call 1-800-LUNGUSA (1-800-586-4872) or visit the newly redesigned website: Lung.org.